Faculty and Staff News
See what’s in store for the All School Meeting on May 4
You won’t want to miss the IU School of Medicine spring All School Meeting on Tuesday, May 4. The online event will begin at 5 pm, and registration is available. Highlights of the meeting include:
- Update from Indiana University President Michael A. McRobbie
- School update from Dean Jay L. Hess, MD, PhD, MHSA
- Research discoveries by IU School of Medicine faculty, presented by Tatiana Foroud, PhD, executive associate dean for research affairs
- Recognition of IU School of Medicine Trustees’ Teaching Award recipients, presented by Paul Wallach, MD, executive associate dean for educational affairs and institutional improvement
- Results of the faculty election
All faculty, staff and learners are invited to attend the meeting, which will include time for questions and answers. The school’s All School Meeting is held twice a year in the spring and fall. Visit the Faculty Steering Committee webpage for more details.
More Hoosiers now eligible for vaccination
As of Wednesday, March 31, Indiana residents age 16+ can schedule a COVID-19 vaccination appointment. Sign up online at ourshot.in.gov or by phone at 211. Don’t forget—visit coronavirus.in.gov for current eligibility information and vaccine details. The latest COVID-19 information from Indiana University is available at covid.iu.edu.
This week’s “Ask Aaron” is all about vaccines; watch the recording
Want to know the latest on the COVID-19 vaccines? This week’s “Ask Aaron” webinar focuses entirely on the vaccines and includes guidance from infectious diseases specialist Lana Dbeibo, MD, assistant professor of clinical medicine and director of vaccination at IU.
The weekly webinars are hosted by IU School of Medicine’s Aaron Carroll, MD, one of the leaders of IU’s COVID-19 medical response team, to provide current information about the virus and the university’s efforts to keep its campus populations safe.
IU School of Medicine Education Day is in three weeks; sign up now
Exploring the theme of adaptability in medical education, IU School of Medicine Education Day will be held virtually from noon-5:30 pm on Thursday, April 22. The second annual event will provide a chance for students, residents, fellows, faculty and staff from all departments and campuses to showcase their medical education research. Oral presentations, small group discussions, workshops and poster sessions will be part of the event. Register now for the event and read the Research in Medical Education blog post for more details. Registration deadline is Tuesday, April 20.
On the blog: Elite swimmer motivated by medical setbacks pursues career as healer
Many medical students take a gap year during their education, often to pursue research or other career-building opportunities. For Chip Peterson, he spent several years before medical school cultivating a different kind of career: professional open-water swimming.
Peterson achieved several accomplishments as a young swimmer, winning the U.S. and world championships in 10-kilometer open-water swimming in 2005. He completed his undergraduate degree at the University of North Carolina, where he focused more on pool swimming, winning the ACC championship in the 1650-yard freestyle. After graduating, he considered pursuing a PhD, but decided to spend a few years swimming full-time instead.
Unfortunately, some health issues made that career difficult.
“I had ulcerative colitis and ended up having a total colectomy during my time as an athlete,” Peterson said. “I narrowly missed a chance to compete in the 2008 Olympics for open-water swimming, partially because of an ulcerative colitis flare.”
Peterson was diagnosed while in college. He had to take some time off from swimming to focus on healing. Once he had the colectomy, eventually he was able to get back to training at the elite level, winning the gold in 10-kilometer open-water swimming at the Toronto Pan American Games in 2015.
“The surgery really turned things around, and I didn’t have to worry about if tomorrow I will have a flare and if all the training I had been doing was just going to go down the drain,” Peterson said. “It was important for me to go back and continue training and get back to the elite level before moving on to studying medicine.”
Peterson said it was the medical professionals who helped with his condition that made him want to attend medical school and eventually pursue a residency in urology. He’ll begin his residency training at IU School of Medicine this summer. Read why Peterson chose to specialize in urology in the Spirit of Medicine blog post.
IU exceeds several underrepresented population recruitment goals in COVID-19 vaccine study
Of the thousands of participants who enrolled across the United States in the late-stage clinical study of an investigational COVID-19 vaccine known as AZD1222, 530 Indiana residents participated in the study at the IU School of Medicine site. AstraZeneca released the results of this nationwide study saying, “the vaccine is 76% effective at preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization.”
“We want to thank the thousands of Indiana residents who volunteered to take part in this important research study,” said Cynthia Brown, MD, associate professor of clinical medicine who led the study at the IU School of Medicine site. “We are especially grateful to those who have been historically underrepresented in clinical trials for their participation.”
Researchers at the IU School of Medicine study site and staff at the Indiana Clinical and Translational Sciences Institute (CTSI) set bold goals to recruit participants who are representative of the demographics of Indiana, which includes several historically underrepresented groups.
Visit the Newsroom to view the demographic enrollment breakdown.
Study: Teplizumab delays diabetes for up to three years
A recent study published in Science Translational Medicine showed that a single 14-day course of teplizumab delayed the onset of Type 1 diabetes for almost three years. This follows a 2019 trial that established a delay for up to two years in high-risk individuals. The study, led by TrialNet investigator and IU School of Medicine physician scientist Emily K. Sims, MD, also showed that teplizumab treatment improved beta cell function and insulin production in trial participants.
The trial followed high-risk relatives of people with Type 1 diabetes who have two or more autoantibodies and abnormal glucose levels. People who meet these criteria are believed to have almost a 100 percent lifetime risk of being clinically diagnosed with Type 1 diabetes. Sims and TrialNet co-investigators will continue to monitor effects and changes in trial participants. Read the TrialNet release.
Precision Health Initiative leaders discuss sustainability and success at virtual retreat
Key leaders from the IU Precision Health Initiative scientific pillars and disease research teams gathered via a virtual retreat last month to talk about plans to sustain the success of the initiative after the first five years of the program end in August of this year. The IU Precision Health Initiative was the first Grand Challenge announced by Indiana University back in 2016. Since then, 55 new faculty members have been hired, as well as 117 nontenured employees. More than 820 peer-reviewed studies have been published and more than $89 million in grant funding has been awarded. The initiative has also created more than 350 new jobs.
Integration of the initiative’s progress at IU Health is key to the success and sustainability of precision health at IU. Specifically, progress in precision health research now needs to translate and integrate into IU Health patient care.
The cardiovascular, neuroscience and cancer institutes, established to strengthen the alignment between IU School of Medicine and IU Health, will play an important role in the next phase of precision health. Read this recap of the retreat to learn more.
Faculty and Staff News
Apply now for PLUS career development cohort program
PLUS (Program to Launch Underrepresented in Medicine Success) is designed to support the career development of underrepresented faculty in academic medicine. A two-year cohort program, PLUS is structured around the two pillars of leadership and scholarship, and bolstered by networking, advising, career coaching and wellness programming that is tailored to meet the needs of faculty underrepresented in medicine. Learn more and apply.
Miller named senior deputy editor of Journal of Clinical Oncology
Kathy Miller, MD, Ballvé Lantero Professor of Oncology, has been selected as the senior deputy editor of the Journal of Clinical Oncology. The peer-reviewed journal is the flagship publication of the American Society of Clinical Oncology and serves as a “credible, authoritative resource for disseminating significant clinical oncology research.” The journal focuses on clinical cancer research and is a leading source worldwide for guidelines related to the diagnosis and treatment of cancer.
Historic IMS to host mass vaccination clinic this month
The race to end the COVID-19 pandemic continues—this month at the Indianapolis Motor Speedway (IMS). IMS, in partnership with IU Health and the Indiana State Department of Health, is hosting a multi-day mass vaccination clinic at the historic oval in April. The clinic provides the single-dose Johnson & Johnson vaccine and will be held from 9 am-7 pm on the following days:
- April 1-3
- April 13-18
- April 24-30
Registration is required in advance at ourshot.in.gov.
Apply by May 3 for Dr. Charles Fisch Cardiovascular Research Award
The objective of the Dr. Charles Fisch Cardiovascular Research Award is to support cardiovascular research for young investigators or more senior investigators embarking on a new research direction.
Faculty members with a primary appointment in the tenure, clinical or research tracks in the division of cardiology, IU School of Medicine Department of Medicine, who do not have more than $200,000 intramural or extramural research support are eligible to apply. Clinical fellows, postdoctoral researchers and students in the division of cardiology may apply for funding to support research training under a faculty member in the division of cardiology. Application deadline is Monday, May 3. Get more details and apply.
Deutsch oncology research fund supports postdocs and students
The Walter A. and Laura W. Deutsch Research Fund was created to assist PhD students, MD/PhD students and postdoctoral fellows pursuing degrees in biomedical sciences. Demonstrating an interest in and potential for conducting oncology research, fund recipients must not have received any other type of scholarship or grant for the upcoming academic year. View the application for more information. The deadline for recommendation letters is Tuesday, June 1. Questions? Email Katie Sodrel.
June 1 is deadline to apply for IUSCCC Hester scholarship
The IU Simon Comprehensive Cancer Center (IUSCCC) Merilyn Hester Scholarship fund was created to assist medical and/or PhD students pursuing degrees in biomedical sciences. Demonstrating an interest in and potential for conducting pediatric hematology or pediatric oncology research, scholarship recipients must not have received any other type of scholarship or grant for the upcoming academic year. Successful applicants are students who have a strong academic record, have outstanding character and well-defined professional goals. View the application for more information. Deadline to apply is Tuesday, June 1. Questions? Email Katie Sodrel.